Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index

LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

Prior Day Closing Value7150.924778.07
Prior Day Change %-1.68%+1.93%
Current Value
Current Day Change %-0.45%-1.71%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Jul 03, 2017)

No. of Constituents 36
Total Market Cap ($ in millions) 642,259
Mean Market Cap ($ in millions) 17,841
Median Market Cap ($ in millions) 3,615
Largest Constituent ($ in millions) 127,360
Smallest Constituent ($ in millions) 436

Market Cap Breakdown (Jul 03, 2017)

Top 10 Constituents (Jul 03, 2017)

Constituent Ticker Weight
Clovis Oncology Inc CLVS 3.83%
Exelixis Inc EXEL 3.28%
Vanda Pharmaceuticals Inc VNDA 3.15%
Enanta Pharmaceuticals Inc ENTA 3.08%
Acorda Therapeutics Inc ACOR 3.03%
Keryx Biopharmaceuticals Inc KERX 3.01%
Radius Health Inc RDUS 2.88%
Theravance Biopharma Inc TBPH 2.86%
Gilead Sciences Inc GILD 2.83%
Bioverativ Inc BIVV 2.82%
Data Updated Monthly
Download All Constituents